Clinical trialNCT01128153CompletedPhase 3Interventional

Saxagliptin Triple Oral Therapy

SponsorAstraZenecaEnrollment257Type 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jayanti Visvanthan, MD
AstraZeneca
Study Chair
clinicaltrials.gov ↗
Robert Moses, MBBS
Sydney Diabetes Centre
Principal Investigator
clinicaltrials.gov ↗
Simon Fisher, MD
AstraZeneca
Study Chair
clinicaltrials.gov ↗
Vinod Mattoo, MD
Bristol-Myers Squibb
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Research Site
Broadmeadow, New South Wales, Australia
Research Site
Wollongong, New South Wales, Australia
Research Site
Daw Park, South Australia, Australia
Research Site
Elizabeth Vale, South Australia, Australia
Research Site
Melbourne, Victoria, Australia
Research Site
Camperdown, Australia
Research Site
Herston, Australia

Canada

Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Sydney Mines, Nova Scotia, Canada
Research Site
Thornhill, Ontario, Canada
Research Site
Kensington, Prince Edward Island, Canada

India

Research Site
Karnāl, Haryana, India
Research Site
Bangalore, Karnataka, India
Research Site
Indore, Madhya Pradesh, India
Research Site
Pune, Maharashtra, India
Research Site
Coimbatore, Tamil Nadu, India

South Korea

Research Site
Wŏnju, Gangwon-do, South Korea
Research Site
Goyang, Kyounggi-do, South Korea
Research Site
Daegu, South Korea
Research Site
Seoul, South Korea

Thailand

Research Site
Bangkok, Thailand

United Kingdom

Research Site
Reading, Berks, United Kingdom
Research Site
Ely, Cambridgeshire, United Kingdom
Research Site
Whitstable, Kent, United Kingdom
Research Site
Westbury, Wiltshire, United Kingdom
Research Site
Ashford, United Kingdom
Research Site
Belfast, United Kingdom
Research Site
Blackpool, United Kingdom
Research Site
Chesterfield, United Kingdom
Research Site
Coventry, United Kingdom
Research Site
Glasgow, United Kingdom
Research Site
Peterborough, United Kingdom
Research Site
Wellingborough, United Kingdom

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2010
Primary completion: 30 Jun 2011
Completion: 30 Jun 2011
Last update posted: 10 Aug 2012
Registered enrollment: 257
Registry id: NCT01128153

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.